BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 18192062)

  • 1. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair.
    Rahn JJ; Adair GM; Nairn RS
    Environ Mol Mutagen; 2010 Jul; 51(6):567-81. PubMed ID: 20658648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
    Zhang N; Liu X; Li L; Legerski R
    DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
    Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
    DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.
    Wu Y; Mitchell TR; Zhu XD
    Mech Ageing Dev; 2008 Oct; 129(10):602-10. PubMed ID: 18812185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ERCC1 and ERCC4 (XPF) genes and gene products.
    Manandhar M; Boulware KS; Wood RD
    Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
    Tan LJ; Saijo M; Kuraoka I; Narita T; Takahata C; Iwai S; Tanaka K
    Genes Cells; 2012 Mar; 17(3):173-85. PubMed ID: 22353549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain mapping of the DNA binding, endonuclease, and ERCC1 binding properties of the human DNA repair protein XPF.
    McCutchen-Maloney SL; Giannecchini CA; Hwang MH; Thelen MP
    Biochemistry; 1999 Jul; 38(29):9417-25. PubMed ID: 10413517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.
    Takahata C; Masuda Y; Takedachi A; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2015 Aug; 36(8):841-51. PubMed ID: 26025908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
    Deng XD; Gao Q; Zhang W; Zhang B; Ma Y; Zhang LX; Muer C; Xie Y; Liu Y
    J Forensic Leg Med; 2017 Jul; 49():15-19. PubMed ID: 28486142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
    Bhagwat N; Olsen AL; Wang AT; Hanada K; Stuckert P; Kanaar R; D'Andrea A; Niedernhofer LJ; McHugh PJ
    Mol Cell Biol; 2009 Dec; 29(24):6427-37. PubMed ID: 19805513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
    Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
    Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
    Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
    Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
    Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
    EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells.
    Niedernhofer LJ; Essers J; Weeda G; Beverloo B; de Wit J; Muijtjens M; Odijk H; Hoeijmakers JH; Kanaar R
    EMBO J; 2001 Nov; 20(22):6540-9. PubMed ID: 11707424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the function of xeroderma pigmentosum group F protein in psoralen interstrand cross-link-mediated DNA repair and mutagenesis.
    Chen Z; Xu XS; Harrison J; Wang G
    Biochem J; 2004 Apr; 379(Pt 1):71-8. PubMed ID: 14728600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.